Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Alveolar repair following LPS-induced injury requires cell-ECM interactions
Jennifer M.S. Sucre, Fabian Bock, Nicholas M. Negretti, John T. Benjamin, Peter M. Gulleman, Xinyu Dong, Kimberly T. Ferguson, Christopher S. Jetter, Wei Han, Yang Liu, Seunghyi Kook, Jason J. Gokey, Susan H. Guttentag, Jonathan A. Kropski, Timothy S. Blackwell, Roy Zent, Erin J. Plosa
Jennifer M.S. Sucre, Fabian Bock, Nicholas M. Negretti, John T. Benjamin, Peter M. Gulleman, Xinyu Dong, Kimberly T. Ferguson, Christopher S. Jetter, Wei Han, Yang Liu, Seunghyi Kook, Jason J. Gokey, Susan H. Guttentag, Jonathan A. Kropski, Timothy S. Blackwell, Roy Zent, Erin J. Plosa
View: Text | PDF
Research Article Cell biology Pulmonology

Alveolar repair following LPS-induced injury requires cell-ECM interactions

  • Text
  • PDF
Abstract

During alveolar repair, alveolar type 2 (AT2) epithelial cell progenitors rapidly proliferate and differentiate into flat AT1 epithelial cells. Failure of normal alveolar repair mechanisms can lead to loss of alveolar structure (emphysema) or development of fibrosis, depending on the type and severity of injury. To test if β1-containing integrins are required during repair following acute injury, we administered E. coli lipopolysaccharide (LPS) by intratracheal injection to mice with a postdevelopmental deletion of β1 integrin in AT2 cells. While control mice recovered from LPS injury without structural abnormalities, β1-deficient mice had more severe inflammation and developed emphysema. In addition, recovering alveoli were repopulated with an abundance of rounded epithelial cells coexpressing AT2 epithelial, AT1 epithelial, and mixed intermediate cell state markers, with few mature type 1 cells. AT2 cells deficient in β1 showed persistently increased proliferation after injury, which was blocked by inhibiting NF-κB activation in these cells. Lineage tracing experiments revealed that β1-deficient AT2 cells failed to differentiate into mature AT1 epithelial cells. Together, these findings demonstrate that functional alveolar repair after injury with terminal alveolar epithelial differentiation requires β1-containing integrins.

Authors

Jennifer M.S. Sucre, Fabian Bock, Nicholas M. Negretti, John T. Benjamin, Peter M. Gulleman, Xinyu Dong, Kimberly T. Ferguson, Christopher S. Jetter, Wei Han, Yang Liu, Seunghyi Kook, Jason J. Gokey, Susan H. Guttentag, Jonathan A. Kropski, Timothy S. Blackwell, Roy Zent, Erin J. Plosa

×

Figure 10

β1AT2-KO mice fail to repopulate alveolus with cells of AT1 morphology.

Options: View larger image (or click on image) Download as PowerPoint
β1AT2-KO mice fail to repopulate alveolus with cells of AT1 morphology.
...
(A) Low-power images of Cre+ mTmG control mice demonstrate Cre-recombinase reporter–labeled GFP+ cells of both AT1 and AT2 cell shape repopulate the injured alveolus 21 days after LPS. GFP-labeled cells in β1AT2-KO mTmG mice retain only AT2 morphology and fail to attain an AT1 cell shape at 21 days. (B) Quantification of mean GFP fluorescence intensity shows decreased area of lung repopulated by GFP-labeled cells at 21 days post-LPS in β1AT2-KO mTmG mice (n = 4 Cre+ mTmG and 6 β1AT2-KO mTmG mice; 10 original magnification, 20×, sections/mouse, P = 0.0087 by 2-tailed t test). (C) High-power images of Cre+ mTmG and β1AT2-KO mTmG lung sections immunostained for pro–SP-C (red) and AGER (blue); tomato omitted in imaging. Large, round GFP+-labeled cells acquire both AT2 (pro–SP-C+) and AT1 (AGER+) markers in β1AT2-KO mTmG lungs. GFP+-labeled cells possess either AT2 or AT1 markers at 21 days post-LPS in Cre+ mTmG lungs. * P < 0.05. Scale bar = 200 μm in A and 25 μm in C.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts